To test for a causal link between FMD-induced CCL2 decline, reduced renal monocyte recruitment, and kidney failure, we treated FMD or ad lib BALB/c male mice with a CCR2 inhibitor (CCR2i) after AA injection (Figure S1B). The gene discussed is CCR2; the disease is kidney failure.